+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Blood Glucose Monitoring Devices Market 2021-2025

  • ID: 5145603
  • Report
  • June 2021
  • Region: Global
  • 120 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Abbott Laboratories
  • Agamatrix Inc.
  • ARKRAY Inc.
  • Dexcom Inc.
  • F. Hoffmann La Roche Ltd.
  • Johnson and Johnson Inc.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the blood glucose monitoring devices market and it is poised to grow by $ 5.84 bn during 2021-2025, progressing at a CAGR of 8.16% during the forecast period. Our report on the blood glucose monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.



The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising global burden of diabetes and technological advances in BGM devices.



The blood glucose monitoring devices market analysis includes the product segment and geographic landscape.



The blood glucose monitoring devices market is segmented as below:


By Product


  • SMBG
  • CGM
  • Lancets

By Geography


  • North America
  • Europe
  • Asia
  • ROW

This study identifies the availability of reimbursement for BGM devices as one of the prime reasons driving the blood glucose monitoring devices market growth during the next few years.



The report on blood glucose monitoring devices market covers the following areas:

  • Blood glucose monitoring devices market sizing
  • Blood glucose monitoring devices market forecast
  • Blood glucose monitoring devices market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood glucose monitoring devices market vendors that include Abbott Laboratories, Agamatrix Inc., ARKRAY Inc., Dexcom Inc., F. Hoffmann La Roche Ltd., Medtronic Plc, Johnson and Johnson Inc., Terumo Europe NV, Ascensia Diabetes Care Holdings AG, and Trivida Health Inc. Also, the blood glucose monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.



The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape



The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Agamatrix Inc.
  • ARKRAY Inc.
  • Dexcom Inc.
  • F. Hoffmann La Roche Ltd.
  • Johnson and Johnson Inc.

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • SMBG - Market size and forecast 2020-2025
  • CGM - Market size and forecast 2020-2025
  • Lancets - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Agamatrix Inc.
  • ARKRAY Inc.
  • Ascensia Diabetes Care Holdings AG
  • Dexcom Inc.
  • F. Hoffmann La Roche Ltd.
  • Johnson and Johnson Inc.
  • Medtronic Plc
  • Terumo Europe NV
  • Trivida Health Inc.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • SMBG - Market size and forecast 2020-2025 ($ million)
  • SMBG - Year-over-year growth 2020-2025 (%)
  • CGM - Market size and forecast 2020-2025 ($ million)
  • CGM - Year-over-year growth 2020-2025 (%)
  • Lancets - Market size and forecast 2020-2025 ($ million)
  • Lancets - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Key customers
  • Abbott Laboratories - Segment focus
  • Agamatrix Inc. - Overview
  • Agamatrix Inc. - Product and service
  • Agamatrix Inc. - Key offerings
  • Agamatrix Inc. - Key customers
  • Agamatrix Inc. - Segment focus
  • ARKRAY Inc. - Overview
  • ARKRAY Inc. - Product and service
  • ARKRAY Inc. - Key offerings
  • ARKRAY Inc. - Key customers
  • ARKRAY Inc. - Segment focus
  • Ascensia Diabetes Care Holdings AG - Overview
  • Ascensia Diabetes Care Holdings AG - Product and service
  • Ascensia Diabetes Care Holdings AG - Key offerings
  • Ascensia Diabetes Care Holdings AG - Key customers
  • Ascensia Diabetes Care Holdings AG - Segment focus
  • Dexcom Inc. - Overview
  • Dexcom Inc. - Business segments
  • Dexcom Inc. - Key offerings
  • Dexcom Inc. - Key customers
  • Dexcom Inc. - Segment focus
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Key customers
  • F. Hoffmann La Roche Ltd. - Segment focus
  • Johnson and Johnson Inc. - Overview
  • Johnson and Johnson Inc. - Business segments
  • Johnson and Johnson Inc. - Key offerings
  • Johnson and Johnson Inc. - Key customers
  • Johnson and Johnson Inc. - Segment focus
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Key customers
  • Medtronic Plc - Segment focus
  • Terumo Europe NV - Overview
  • Terumo Europe NV - Product and service
  • Terumo Europe NV - Key offerings
  • Terumo Europe NV - Key customers
  • Terumo Europe NV - Segment focus
  • Trivida Health Inc. - Overview
  • Trivida Health Inc. - Product and service
  • Trivida Health Inc. - Key offerings
  • Trivida Health Inc. - Key customers
  • Trivida Health Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Agamatrix Inc.
  • ARKRAY Inc.
  • Dexcom Inc.
  • F. Hoffmann La Roche Ltd.
  • Johnson and Johnson Inc.
The publisher recognizes the following companies as the key players in the global blood glucose monitoring devices market: Abbott Laboratories, Agamatrix Inc., ARKRAY Inc., Dexcom Inc., F. Hoffmann La Roche Ltd., Medtronic Plc, Johnson and Johnson Inc., Terumo Europe NV, Ascensia Diabetes Care Holdings AG, and Trivida Health Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the availability of reimbursement for BGM devices.`

According to the report, one of the major drivers for this market is the rising global burden of diabetes.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Agamatrix Inc.
  • ARKRAY Inc.
  • Dexcom Inc.
  • F. Hoffmann La Roche Ltd.
  • Medtronic Plc
  • Johnson and Johnson Inc.
  • Terumo Europe NV
  • Ascensia Diabetes Care Holdings AG
  • Trivida Health Inc.
Note: Product cover images may vary from those shown